Salvatore Alfieri

Medicine & Life Sciences

1. HhAntag691 100%
2. Nasopharyngeal Neoplasms 86%
3. Cohort Studies 62%
4. Multicenter Studies 57%
5. Nasopharyngeal Carcinoma 52%
6. Abiraterone Acetate 48%
7. Cell Dedifferentiation 46%
8. SARS Virus 45%
9. Salivary Gland Neoplasms 44%
10. Drug Therapy 43%
11. Survival 39%
12. Safety 38%
13. Cell-Free Nucleic Acids 38%
14. Intensity-Modulated Radiotherapy 37%
15. Nutrition Assessment 36%
16. Head and Neck Neoplasms 35%
17. Basal Cell Carcinoma 34%
18. Castration 33%
19. Androgen Receptors 33%
20. Propensity Score 32%
21. Pandemics 32%
22. Gastrectomy 31%
23. Human Herpesvirus 4 30%
24. Insulin Secretion 30%
25. Fatigue 30%
26. Survival Analysis 29%
27. Salivary Glands 29%
28. Practice Guidelines 28%
29. Radiotherapy 27%
30. Stomach Neoplasms 26%
31. abiraterone 23%
32. Neoplasms 23%
33. Depression 20%
34. Cross-Sectional Studies 20%
35. Androgens 18%
36. Guidelines 17%
37. Disease-Free Survival 17%
38. Carcinoma 16%
39. Type 2 Diabetes Mellitus 15%
40. Population 15%
41. Lymph Node Ratio 12%
42. Odds Ratio 11%
43. Therapeutics 11%
44. Quality of Life 11%
45. Comorbidity 10%
46. Gonadotropin-Releasing Hormone 10%
47. Progression-Free Survival 9%
48. Logistic Models 9%
49. Incidence 8%
50. Postoperative Complications 7%